Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their efficacy and safety.
European stocks were set for a mixed open on Tuesday, with results out from HSBC, Lufthansa, Volvo Cars, Adidas, BP, AstraZeneca, Deutsche Bank and more.
If the tariff-loving Trump goes ahead with his plans, it will hit AstraZeneca - the most valuable company on the UK stock market - and also rival GSK, another stalwart of the FTSE 100.
If the tariff-loving Trump goes ahead with his plans, it will hit AstraZeneca - the most valuable company on the UK stock market - and also rival GSK, another stalwart of the FTSE 100.